Methyl Aminolevulinate Hydrochloride Patent Expiration
Methyl Aminolevulinate Hydrochloride is Used for treating actinic keratoses using photodynamic therapy. It was first introduced by Galderma Laboratories Lp
Methyl Aminolevulinate Hydrochloride Patents
Given below is the list of patents protecting Methyl Aminolevulinate Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Metvixia | US6034267 | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar 08, 2016
(Expired) | Galderma Labs Lp |
Methyl Aminolevulinate Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List